The Nanotherapeutics Lab advances nanomedicine by bridging innovative research with clinically translatable therapies. We focus on diseases where current treatments remain inadequate, developing novel strategies using diverse nanomaterials to address key therapeutic challenges. Our work combines engineering of nanoscale systems with clinically relevant disease models, with a strong emphasis on combination approaches that integrate nanomedicine with existing treatment modalities to enhance real-world applicability.